WHO ICTRP trial

Treatment of sleep-disordered breathing with predominant central sleep apnoea by…

NL-OMON37747 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting

Key facts

Trial ID NL-OMON37747
Public title Treatment of sleep-disordered breathing with predominant central sleep apnoea by adaptive servo ventilation in patients with heart failure (Major Substudy of SERVE-HF)
Scientific title Treatment of sleep-disordered breathing with predominant central sleep apnoea by adaptive servo ventilation in patients with heart failure (Major Substudy of SERVE-HF) - SERVE-HF major substudy
Primary sponsor Europe ResMed Germany Inc
Registry Overview of Medical Research in the Netherlands (NL-OMON)
Recruitment status Not Recruiting
Study type Interventional
Phase 4
Countries Australia;Germany;Netherlands ;United States of America
Conditions sleep disordered breathing, predominantly central sleep apnea syndrome central sleep apnea heart failure;10019280;central sleep apnea;heart failure
Interventions see for more information ABR form SERVE-HF ;heart failure;quality of life;sleep disordered breathing;ventricular function
Registration date Jun 19, 2012
Target size 6
Secondary IDs NCT01164592;NL39176.042.11
Registry page onderzoekmetmensen.nl

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations